These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38260847)

  • 1. Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival.
    Jiang B; Qiu M; Qin L; Tang J; Zhan S; Lin Q; Wei J; Liu Y; Zhou Z; Liang X; Cao J; Lian J; Mai Y; Jiang Y; Yu H
    Front Oncol; 2023; 13():1252158. PubMed ID: 38260847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially functional variants of
    Huang Q; Liu Y; Qiu M; Lin Q; Wei X; Zhou Z; Liang X; Li R; Chen W; Zhou X; Yu H
    Front Oncol; 2022; 12():990160. PubMed ID: 36119471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Variants in p53 Pathway Genes Affect Survival of Patients with HBV-Related Hepatocellular Carcinoma.
    Qin L; Qiu M; Tang J; Liu S; Lin Q; Huang Q; Wei X; Wen Q; Chen P; Zhou Z; Cao J; Liang X; Guo Q; Nong C; Gong Y; Wei Y; Jiang Y; Yu H; Liu Y
    J Hepatocell Carcinoma; 2024; 11():1541-1555. PubMed ID: 39156673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients.
    Lin Q; Qiu M; Wei X; Xiang Z; Zhou Z; Ji I; Liang X; Zhou X; Wen Q; Liu Y; Yu H
    Arch Toxicol; 2023 Jun; 97(6):1599-1611. PubMed ID: 37029817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
    Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
    Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma.
    Zhan S; Qiu M; Wei X; Wei J; Qin L; Jiang B; Wen Q; Chen P; Lin Q; Wei X; Zhou Z; Jiang Y; Liang X; Li R; Liu Y; Yu H
    Cancer Med; 2024 Jan; 13(1):e6848. PubMed ID: 38151984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel genetic variants in the NLRP3 inflammasome-related PANX1 and APP genes predict survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Liu Y; Fan Y; Gong R; Qiu M; Wei X; Lin Q; Zhou Z; Cao J; Jiang Y; Chen P; Chen B; Yang X; Wei Y; Zhang R; Wen Q; Yu H
    Clin Transl Oncol; 2024 Aug; ():. PubMed ID: 39090420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival.
    Gong R; Qiu M; Cao J; Zhou Z; Wei Y; Wen Q; Lin Q; Wei X; Liang X; Jiang Y; Chen P; Wei J; Zhan S; Liu Y; Yu H
    J Cancer; 2023; 14(18):3387-3396. PubMed ID: 38021150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus-related hepatocellular carcinoma.
    Qin L; Qiu M; Lin Q; Jiang B; Zhan S; Wei X; Wei J; Liu Y; Wen Q; Chen P; Jiang Y; Zhou Z; Liang X; Cao J; Gong Y; Wei Y; Wei X; Yu H
    Cancer Med; 2024 Apr; 13(7):e7040. PubMed ID: 38562021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
    Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
    Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV-related hepatocellular carcinoma survival.
    Qiu M; Lin Q; Liu Y; Chen P; Zhou Y; Jiang Y; Zhou Z; Wen Q; Zhou X; Liang X; Gan H; Yu H
    Mol Carcinog; 2023 Sep; 62(9):1378-1387. PubMed ID: 37278562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.
    Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H
    Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.
    Zeng Z; Liao X; Huang K; Han C; Qin W; Su H; Ye X; Yang C; Zhou X; Wei Y; Mo S; Liu J; Lan C; Huang X; Huang Z; Peng K; Gao Q; Peng T; Zhu G
    World J Surg Oncol; 2023 Oct; 21(1):322. PubMed ID: 37833735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis.
    Mai H; Xie H; Hou J; Chen H; Zhou B; Hou J; Jiang D
    J Hepatocell Carcinoma; 2021; 8():1055-1064. PubMed ID: 34513747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
    Liu X; Yu L; Han C; Lu S; Zhu G; Su H; Qin W; Liao X; Peng T
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):739-747. PubMed ID: 27288300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional variant in the RAD51 3' UTR is associated with survival of hepatocellular carcinoma patients.
    Qiu M; Liu Y; Lin Q; Jiang Y; Zhou Z; Wen Q; Liang X; Zhou X; Yu H
    Gene; 2023 Jan; 851():146964. PubMed ID: 36261080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.